Clarivate Plc
CLVT-PA
New York Stock Exchange4.02
USD
+0.32
- -
CIK
0001764046
ISIN
JE00BM91P354
Return %
Stock
S&P500
1Y
-85.67
26.57
3Y
-93.32
76.60
5Y
-95.97
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jonathan Gear
- Full Time Employees
- 12,000
- Sector
- Technology
- Industry
- Information Technology Services
- Address
- 70 St. Mary Axe London United Kingdom EC3A 8BE
- IPO Date
- Jun 10, 2021
- CIK
- 0001764046
- Website
- clarivate.com
- Similar Companies
- Business
- Clarivate Plc provides transformative intelligence through enriched data, insights, analytics, workflow solutions, and expert services focused on academia and government, intellectual property, and life sciences and healthcare; its core products include Web of Science for bibliometrics and citation indexing, Cortellis for life sciences intelligence covering regulatory, competitive, clinical trials, deals, drug discovery, and generics intelligence, Derwent for patent analytics and the Derwent World Patents Index, CompuMark for trademark searching and protection, CPA Global for IP lifecycle management and renewals, ProQuest for academic content and research tools, and additional offerings such as EndNote, Publons, MarkMonitor for brand protection, and AI-powered platforms like the Academic AI Platform and Cortellis Regulatory AI Assistant. The company serves customers including top universities, pharmaceutical and biotech firms, R&D organizations, governments, and legal services across more than 180 countries with over 12,000 employees in 40+ countries. Founded in 2016 from the Thomson Reuters Intellectual Property and Science division and headquartered in London, United Kingdom, Clarivate operates through segments including Academia and Government, Intellectual Property, and Life Sciences and Healthcare. Recent developments encompass the expansion of its Academic AI Platform with AI Agents and Agent Builder launched in April 2025, the introduction of the Cortellis Regulatory AI Assistant in December 2025 to enhance regulatory compliance, the acquisition of Rowan TELS in July 2024 to bolster patent practitioner support, divestiture of ScholarOne in November 2024, and a strategic review announced in late 2024 considering divestitures of non-core academic and IP management units to refocus on high-margin analytics, alongside share repurchases and debt repayment in 2025 under its Value Creation Plan.